Story

Synthomer Lifts 2026 Outlook on Strong First-Half Revenue Growth

ENTHMSVIIDZHZH-TWJAKOHI
Aug 4, 20261 min read
Synthomer Lifts 2026 Outlook on Strong First-Half Revenue Growth
Text size
Background

UK speciality polymers supplier Synthomer upgraded its full-year 2026 outlook on Tuesday after reporting a 6.7% year-over-year increase in first-half revenue and a return to adjusted profitability. The company said growth was driven by strategic initiatives and a focus on higher-margin products.

First-Half Performance

Synthomer posted first-half revenue of £954.30 million, with growth recorded across all its divisions. The company's financial results significantly outperformed analyst expectations.

Key figures for the first half include:

  • Adjusted earnings per share (EPS) reached £0.22, turning positive from a loss in the prior-year period and beating a consensus analyst estimate of £0.05.
  • Adjusted pretax profit came in at £12.70 million, ahead of the £11 million estimate.
  • Adjusted EBITDA was reported at £96.70 million.

On a statutory basis, the company recorded a pretax loss of £25.50 million and a basic loss per share of £0.03. Free cash flow for the period was negative £80.80 million.

Upgraded Outlook

Sample IUX Markets – In-articleAd

Following the strong first-half results, Synthomer raised its guidance for the full year. The company now expects its 2026 results to be slightly ahead of market expectations.

Synthomer also anticipates that its full-year free cash flow, before non-recourse receivables finance movements, will be positive. The company forecasts its year-end 2026 covenant net debt to EBITDA ratio will be between 4.0 and 4.35 times, excluding any further divestments.

Business Drivers and Context

According to the company, the improved underlying earnings were the result of strategic growth initiatives, innovation, and a successful shift toward higher-margin speciality products. Margin improvements were also supported by ongoing cost and efficiency programs.

Synthomer noted that its Health & Protection division saw temporary volume gains due to supply chain disruptions at competitors. The company stated that it does not expect these specific gains to continue into the second half of the year.

Read next

More on Stocks
Back to latest news

LATEST